Cargando…
Circulating Bacterial DNA: A New Paradigm for Cancer Diagnostics
Cell-free DNA applications for screening, diagnosis and treatment monitoring are increasingly being developed for a range of different cancers. While most of these applications investigate circulating tumor DNA (ctDNA) or methylation profiles of ctDNA, circulating bacterial DNA (cbDNA) has also been...
Autores principales: | Glyn, Tamara, Purcell, Rachel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013860/ https://www.ncbi.nlm.nih.gov/pubmed/35445046 http://dx.doi.org/10.3389/fmed.2022.831096 |
Ejemplares similares
-
Diagnostic and Prognostic Value of Circulating CircRNAs in Cancer
por: Wang, Mina, et al.
Publicado: (2021) -
Circulating Epstein-Barr virus DNA associated with hepatic impairment and its diagnostic and prognostic role in patients with gastric cancer
por: He, Hui-Chan, et al.
Publicado: (2022) -
Non-steroidal anti-inflammatory drugs and biomarkers: A new paradigm in colorectal cancer
por: Rashid, Gowhar, et al.
Publicado: (2023) -
Editorial: Antimicrobial Photodynamic Therapy: A New Paradigm in the Fight Against Infections
por: Gilaberte, Yolanda, et al.
Publicado: (2021) -
microRNAs: An Emerging Paradigm in Lung Cancer Chemoresistance
por: Naidu, Srivatsava, et al.
Publicado: (2015)